Takeshi Maruyama

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Endoplasmic Reticulum Stress

Top Venues

Seminars in immunopathology

Scientific reports

Nature immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Shiyu Ayukawa, Nagisa Kamoshita, Takeshi Maruyama
Epithelial recognition and elimination against aberrant cells. Seminars in immunopathology (2024)
Shiyu Ayukawa, Nagisa Kamoshita, Takeshi Maruyama
Epithelial recognition and elimination against aberrant cells. Seminars in immunopathology (2024)
Shiyu Ayukawa, Nagisa Kamoshita, Takeshi Maruyama
Epithelial recognition and elimination against aberrant cells. Seminars in immunopathology (2024)
Shiyu Ayukawa, Nagisa Kamoshita, Takeshi Maruyama
Epithelial recognition and elimination against aberrant cells. Seminars in immunopathology 45 (4-6) (2024)
Shiyu Ayukawa, Nagisa Kamoshita, Takeshi Maruyama
Publisher Correction: Epithelial recognition and elimination against aberrant cells. Seminars in immunopathology (2024)
Shiyu Ayukawa, Nagisa Kamoshita, Takeshi Maruyama
Epithelial recognition and elimination against aberrant cells. Seminars in immunopathology 45 (4-6) (2024)
Shiyu Ayukawa, Nagisa Kamoshita, Jun Nakayama, Ryohei Teramoto, Novalia Pishesha, Kenji Ohba, Nanami Sato, Kei Kozawa, Hikari Abe, Kentaro Semba, Nobuhito Goda, Yasuyuki Fujita, Takeshi Maruyama
Epithelial cells remove precancerous cells by cell competition via MHC class I-LILRB3 interaction. Nature immunology 22 (11) (2021)
Saki Takayanagi, Kengo Watanabe, Takeshi Maruyama, Motoyuki Ogawa, Kazuhiro Morishita, Mayumi Soga, Tomohisa Hatta, Tohru Natsume, Tomoya Hirano, Hiroyuki Kagechika, Kazuki Hattori, Tetsushi Tsuruga, Hidenori Ichijo
ASKA technology-based pull-down method reveals a suppressive effect of ASK1 on the inflammatory NOD-RIPK2 pathway in brown adipocytes. Scientific reports 11 (1) (2021)